City

Rochester (1)

Winston-Salem (1)

Overall Status

Completed (2)

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

Mayo Clinic (1)

Wake Forest University Health Sciences (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

autologous dendritic cell-tumor fusion vaccine (1)

cefepime hydrochloride (1)

cryotherapy (1)

dendritic cell vaccine therapy (1)

immunoenzyme technique (1)

immunohistochemistry staining method (1)

laboratory biomarker analysis (1)

pneumococcal polyvalent vaccine (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

adult immunoblastic large cell lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,

Completed

Cutaneous B-cell Non-Hodgkin Lymphoma
+15 more

dendritic cell vaccine therapy
+6 more

Rochester, Minnesota

Mayo Clinic

Jan 13, 2020

Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Burkitt Lymphoma Trial in Winston-Salem (cefepime HCl)

Completed

Adult Acute Lymphoblastic Leukemia
+38 more

cefepime hydrochloride

Winston-Salem, North Carolina

Wake Forest University Health Sciences

Jul 16, 2018